OncologyPharmacist.net
Where Oncology Pharmacists, Residents, & Technicians access Chemotherapy Drug Information, Products, & Programs
Oncology Pharmacist Online Resources

Welcome

OncologyPharmacist.NET is dedicated to providing timely information, consulting services, and links for Clinical Hem/Onc/BMT Pharmacists, Residents, and Technicians, in a single location, to be used on a daily basis. Improving Patient Care through the exchange of information is our goal. Our News and Clinical Tools sections will come from practice sites throughout the world. Our Job Boards will focus on relevant positions exclusively. Our Patient Assistant Programs area will link to sites that provide drugs that are used strictly in Hematology and Oncology. New Drugs will highlight Chemotherapy and Supportive Care drugs with new indications within the last 365 days. Our hope is to integrate CMS coding and announcements in the future as well as provide an area for Hem/Onc/BMT Residents, Technicians, and Practitioners to exchange ideas. Please bookmark our site, sign up to be listed on our Advisory Board Clinicians or Speakers List, send us suggestions or guidelines to improve the site, and consider advertising in this exciting domain. OP


Links of Interest

www.usp.org CSP and chemo safety guidelines
www.jointcommission.org Safety goals
www.nccn.org Chemo guidelines
www.asco.org Chemo guidelines
www.ashp.org Chemo and safety guidelines
www.pharmecology.com Wast Stream Management Guidelines
www.fda.gov/Safety/MedWatch/default.htm MedWatch reporting program
oncologypharmacist.net Consulting services and practice sites
www.hoparx.org Hematology/Oncology Pharmacy Association
chemorders.com Chemotherapy Order Templates
Postmarket Safety Information For Patients and Providers
anti-cancerdrugs.com Lippincott Williams & Wilkins
BioMedSearch.com Biomedical Search Engine

Newsfeed

Cancer / Oncology News From Medical News Today
Latest Health News and Medical News posted throughout the day, every day.

Global Hepatitis B epidemic can be treated for $36 (24) per person per year
Scientists at the University of Liverpool have demonstrated that a drug for treating hepatitis B virus (HBV) could be mass-produced for only 24 ($36) per person per year, versus the current UK NHS...
Ovary removal linked with 62% reduction in BRCA1-related breast cancer deaths
The benefits of oophorectomy, the procedure to remove the ovaries, are confirmed in a new study published in JAMA Oncology that examines survival among breast cancer patients.
TLR5 genetic variants may predict antitumor responses to entolimod
Roswell Park Cancer Institute (RPCI) researchers examined the characteristics of genetic variants in human toll-like receptor 5 (TLR5), and have found that these genetic variants may predict...
Genomic analyses point to the potential of personalised care for liver cancer...
A new study presented at The International Liver Congress 2015 shows that by using genomic analyses to understand how and when carcinogenic mutations occur in patients with hepatocellular carcinoma...
Transgene announces new pre-clinical data for two of its programs - TG4010 an...
Transgene SA has announced that new pre-clinical data for two of its programs - TG4010 and TG3003 - were presented at the Annual Meeting of the American Association for Cancer Research (AACR) in...

Newsfeed display by CaRP

Search:

Headquarters: Warwick, RI • ©2009 OncologyPharmacist.net  
privacy statement | terms of service